Resources

Program Resources | Presentations

Presentations

2006 | 2005 | 2004 | 2003 | 2002 | 2001

CERTs Presentations 2002

Spreading the Word About CERTs (11k pdf)

Dec | Nov | Oct | Sept | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan

December 19, 2002
Institute of Medicine Committee on Smallpox Vaccination Program Implementation
Smallpox Willingness: A National Study of Emergency Department Personnel
Worth W. Everett, MD
Washington, DC

December 16, 2002
Medicine and Pharmaceuticals Working Group of the National Children's Study
Ascertaining Drug Exposures in Pregnant Women and Children: What Can Health Plans Contribute
Jonathan Finkelstein, MD, MPH
Baltimore, Maryland

December 16, 2002
National Academies Institute of Medicine and Clinical Research Roundtable
Robert M. Califf, M.D.
Washington, DC

December 14, 2002
International Workshop on Outcomes in Osteoarthritis
Recent Approaches to Understanding Pain in Hip and Knee Osteoarthritis
Laurence A. Bradley, PhD
Indianapolis, Indiana

December 9, 2002
University of Maryland Rheumatology Grand Rounds
Outcomes Research in Musculoskeletal Disorders
Kenneth G. Saag, MD, MSc
College Park, Maryland

December 5, 2002
Infectious Diseases Faculty Candidate Research
Antimicrobials and Medical Errors
Darren Linkin, MD
Chicago, Illinois

To Top

November 17-20, 2002
American Heart Association Scientific Sessions 2002
Impact of the Dofetilide Risk Management Program: A Comparison with Sotalol
Nancy Allen LaPointe, PharmD
Chicago, Illinois

November 17-20, 2002
American Heart Association Scientific Sessions 2002
From Controlled Trials to Clinical Practice: Monitoring Transmyocardial Revascularization Use and Outcomes
Padma Kaul, PhD
Chicago, Illinois

November 17, 2002
2002 Research Conference on Research Integrity
Vaccine Safety: A Case Study of the Impact of Privacy Concerns on Public Health Research
Deborah Shatin, PhD, Bharati Manda, MD
Potomac, Maryland

November 15, 2002
Ninth Annual Interdisciplinary Women’s Health Research Symposium
Abnormal Pain Sensitivity in Women with Fibromyalgia
Laurence A. Bradley, PhD
Baltimore, Maryland

November 13, 2002
Electrophysiology Research Conference
The Centers for Education and Research on Therapeutics (CERTs) National Initiative - Duke CERTs Research Center
Nancy M. Allen LaPointe, PharmD
Durham, North Carolina

November 10, 2002
American Public Health Association Annual Meeting
Risk Management from Assessment to Intervention: Regulatory/Public Health Interfaces
Brian L. Strom, MD, MPH
Philadelphia, PA

November 10, 2002
American Public Health Association Annual Meeting
The Centers for Education and Research on Therapeutics: A CERTain Public Health Resource in CERTain Times
Brian L. Strom, MD, MPH
Philadelphia, PA

November 9-13, 2002
American Public Health Association Annual Meeting
Postmarketing Surveillance of Drugs in Emergency Department Pediatric Patients
Anna Waller, ScD and Patricia J. Byrns, MD
Philadelphia, PA

November 1, 2002
Duke University Medical Center Medicine Grand Rounds
Improving Drug Therapy by Thinking Outside the Boxes
Richard Platt, MD, MS
Durham, North Carolina

To Top

October 30-31, 2002
Association of American Medical Colleges Meeting
IT and the Future of Clinical Trials
Robert M. Califf, MD
Leesburg, Virginia

October 26-30, 2002
Canadian Cardiovascular Society 2002
From Controlled Trials to Clinical Practice: Monitoring Transmyocardial Revascularization Use and Outcomes
Padma Kaul, PhD
Edmonton, Alberta, Canada

October 29, 2002
American College of Radiology National Meeting, Clinical Symposium
Pro/Con Debate: Consequences of Chronic Glucocorticoid Use in Late Rheumatoid Arthritis
Kenneth G. Saag, MD, MSc
New Orleans, Louisiana

October 24-27, 2002
Infectious Diseases Society of America
Pharmacy Refill Adherence is a Better Predictor of HIV Outcome than Self-Report
Robert Grossberg, MD
Chicago, Illinois

October 17-20, 2002
40th Annual Meeting of the Infectious Diseases Society of America (IDSA)
VRE Colonization Rate in Liver Transplant Candidates is Low, Despite High Rate of Post-transplant Infections
Elizabeth Hagan, MD, Ebbing Lautenbach, MD, MPH, MSCE
Chicago, Illinois

October 12-14, 2002
American Heart Association 2002 - Quality of Care and Outcomes Research
Economic Impact of Beta-Blocker Therapy in Patients with Congestive Heart Failure
Patricia A. Cowper, PhD
Washington, DC

October 10, 2002
North Carolina Association of Pharmacists Annual Convention/Carolina Seminar...Applying Drug Knowledge to Improve Health
Improving Cardiovascular Drug Therapy: The Duke CERTs Program
Judith M. Kramer, MD, MS
Greensboro, North Carolina

October 10, 2002
North Carolina Association of Pharmacists Annual Convention/Carolina Seminar...Applying Drug Knowledge to Improve Health
Improving Cardiovascular Drug Therapy
Nancy M. Allen LaPointe
Greensboro, North Carolina

October 10, 2002
North Carolina Association of Pharmacists Annual Convention/Carolina Seminar...Applying Drug Knowledge to Improve Health
What's Next For CERTs?
William H. Campbell, PhD; Judith M. Kramer, MD, MS; Hugh H. Tilson, MD, DrPH
Greensboro, North Carolina

October 10, 2002
North Carolina Association of Pharmacists Annual Convention/Carolina Seminar...Applying Drug Knowledge to Improve Health
Improving Pediatric Drug Therapy: The University of North Carolina - Chapel Hill CERTs Program
William H. Campbell, PhD
Greensboro, North Carolina

October 10, 2002
North Carolina Association of Pharmacists Annual Convention/Carolina Seminar...Applying Drug Knowledge to Improve Health
Adverse Drug Events Project
Rowell Daniels, MS, PharmD
Greensboro, North Carolina

October 10, 2002
North Carolina Association of Pharmacists Annual Convention/Carolina Seminar...Applying Drug Knowledge to Improve Health
Improving Drug Therapy for Otitis Media Roundtable Discussion
D.B. Christensen, PhD
Greensboro, North Carolina

October 10, 2002
North Carolina Association of Pharmacists Annual Convention/Carolina Seminar...Applying Drug Knowledge to Improve Health
Otitis Media Project - Improving Drug Therapy - The CERTs
D.B. Christensen, PhD
Greensboro, North Carolina

October 8, 2002
University of Chicago Patient Safety Grand Rounds
Organizing and Improving Care: The Role of Health Care Micro-systems
Julie J. Mohr, MSPH, PhD
Chicago, Illinois

October 7-8, 2002
NINDS Clinical Research Collaboration Workshop
Exploring the Options
Robert M. Califf, MD
Bethesda, Maryland

October 7, 2002
Drug Information Association
Adverse Event Reporting in Academic Medical Centers
Sean Hennessy, PharmD, PhD
New Orleans, Louisiana

October 2-4, 2002
NHLBI - Women and Ischemia Syndrome Evaluation (WISE) Workshop
Diagnosis and Pathophysiology of Ischemic Heart Disease
Robert M. Califf, MD
Baltimore, Maryland

September 22-25, 2002
Heart Failure Society of America
Reducing the Burden of HF/AMI Through Neurohormonal Blockade
Robert M. Califf, MD
Boca Raton, Florida

To Top

September 19, 2002
University of Alabama CERTs and Health Services Advisory Group, Inc., Secondary Prevention of Fractures Project Meeting
Secondary Prevention of Osteoporotic Fractures in Medicare Residents of Skilled Nursing Facilities
Norman W. Weissman, PhD
Phoenix, Arizona

September 13, 2002
Heartquest
Evaluation of the Use of Evidence-Based Therapies by CAD and HF Patients in Robeson & Columbus Counties: Information from the Duke Databank for Cardiovascular Disease
Richeille Ricketts, MPH
Lumberton, North Carolina

September 13, 2002
European Workgroup on Glucocorticoids
Glucocorticoid Drug Interactions
Kenneth G. Saag, MD, MSc
Coimbra, Portugal

September 13, 2002
Meeting of the Swiss Rheumatology Association
Abnormal Pain Sensitivity in Fibromyalgia
Laurence A. Bradley, PhD
Montreux, Switzerland

September 12, 2002
Duke Psychiatric Grand Rounds
What You Should Know about the QT Interval
Sana Al-Khatib, MD, MHS
Durham, North Carolina

September 6, 2002
Medical College of Virginia - Rheumatology and Endocrinology Grand Rounds
Patient Preferences and Provider Practices in Osteoporosis
Kenneth G. Saag, MD, MSc
Richmond, Virginia

September 4, 2002
University of Arizona College of Medicine Medical Grand Rounds
Drug-Induced Arrhythmias
Raymond L. Woosley, MD, PhD
Tucson, Arizona

To Top

August 18-21, 2002
18th International Conference on Pharmacoepidemiology (ICPE)
The US Centers for Education & Research in Therapeutics (CERTs). A Round Table
Hugh H. Tilson, MD, MPH, Lynn A. Bosco, MD, MPH, Brian L. Strom, MD, MPH, Wayne A. Ray, PhD
Edinburgh, Scotland

August 18-21, 2002
18th International Conference on Pharmacoepidemiology (ICPE)
Descriptive Epidemiology of Early-Onset Adverse Effects of Cancer Chemotherapy
Sean Hennessy, PharmD, PhD
Edinburgh, Scotland

August 18-21, 2002
18th International Conference on Pharmacoepidemiology (ICPE)
Lack of Discernible Effects of Retrospective Drug Utilization Review Programs on the Frequency of Presumptive Drug Therapy Problems
Sean Hennessy, PharmD, PhD
Edinburgh, Scotland

August 18-21, 2002
18th International Conference on Pharmacoepidemiology (ICPE)
Reducing Use of Antibiotics for Acute Bronchitis and Upper Respiratory Infection
Sean Hennessy, PharmD, PhD
Edinburgh, Scotland

August 18-21, 2002
18th International Conference on Pharmacoepidemiology (ICPE)
Declining Hospitalization and Mortality Rates From Peptic Ulcer Disease in the 1990s: Correlation with Sales of NSAIDS and Acid Suppression Medications
James D. Lewis, MD, MSCE
Edinburgh, Scotland

August 18-21, 2002
18th International Conference on Pharmacoepidemiology (ICPE)
Low Level Detectable HIV on Antiretroviral Therapy: Treatment Modifications and Outcomes
Robert Gross, MD, MSCE
Edinburgh, Scotland

August 18, 2002
Pre-ICPE Educational Sessions of the 18th International Conference on Pharmacoepidemiology (ICPE)
Advance Topics in Pharmacoepidemiology - Automated Databases: Beyond the Basics
Wayne A. Ray, PhD
Edinburgh, Scotland

August 18, 2002
Pre-ICPE Educational Sessions of the 18th International Conference on Pharmacoepidemiology (ICPE)
Introduction to Pharmacoepidemiology - Case-Control Studies
Sean Hennessy, PharmD, PhD
Edinburgh, Scotland

August 12, 2002
Joint Statistical Meetings
Robustness of Mixed Effects Regression to Model Misspecification in Meta Analysis: Results of Classical and Bayesian Analyses
A. Russell Localio, Jesse A. Berlin, Thomas R. Ten Have
New York, New York

To Top

July 4, 2002
4th Symposium on Systematic Reviews: Pushing the Boundaries
Robustness of Mixed Effects Regression to Model Misspecification in Meta Analysis
A. Russell Localio, Jesse A. Berlin, Thomas R. Ten Have
St. Catherine's College, Oxford, United Kingdom

To Top

June 19, 2002
Drug Information Association 38th Annual Meeting
Maximizing the Rational Use of Therapeutics: Showcasing the Centers for Education & Research on Therapeutics
K. Arnold Chan, MD, ScD, Lesley H. Curtis, PhD, Sean Hennessy, PharmD, PhD
Chicago, Illinois

June 18, 2002
Drug Information Association 38th Annual Meeting
Rational Use of Therapeutics: The Pediatric Population
Lesley H. Curtis, PhD
Chicago, Illinois

June 17, 2002
Drug Information Association 38th Annual Meeting
Evaluating the Dofetilide Risk Management Program: The Duke CERTs Experience
Nancy Allen-LaPointe, PharmD
Chicago, Illinois

June 1, 2002
John Oates Institute
Postmarketing Surveillance
Wayne A. Ray, PhD
Nashville, Tennessee

To Top

May 30, 2002
CERTs Risk Assessment Workshop
Risk Monitoring
Wayne A. Ray, PhD
Chapel Hill, North Carolina

May 29-31, 2002
Postmarketing Assessments of Pharmaceutical Risk Workshop
The Use of Meta-Analysis in Postmarketing Assessment of Risk
Jesse A. Berlin, ScD
Chapel Hill, North Carolina

May 22, 2002
FDA Public Hearing: Risk Management of Prescription Drugs
Centers for Education & Research on Therapeutics (CERTs)
Robert M. Califf, MD
Washington, DC

May 21-22, 2002
American Academy of Pediatrics
Medication Errors in Children: A Descriptive Summary of Medication Error Reports Submitted to the United States Pharmacopeia
Shawn C. Becker, BSN, RN
Rosemont, Illinois

May 19-22, 2002
International Society for Pharmacoeconomic and Outcomes Research 7th Annual International Meeting
The Impact of Antibiotic Selection on Treatment of Outcomes for Acute Otitis Media
A. Ayyar-Krishnan, MS, D.B. Christensen, PhD
Arlington, Virginia

May 16-17, 2002
Drug Information Associations "Risk Management Comes of Age"
Measuring the Impact of a Novel Risk Management Program to Improve Patient Safety
Judith M. Kramer, MD, MS
Bethesda, Maryland

May 15-18, 2002
Society for Investigative Dermatology
Effect of Antibiotics on the Oro-pharyngeal Flora of Individuals with Acne
Ross Levy
Los Angeles, California

May 11, 2002
North American Society of Pacing and Electrophysiology 23rd Annual Scientific Sessions
Outpatient Use of Antiarrhythmic Medications from 1995 through 2000: Does Evidence Influence Medical Practice?
Sana M. Al-Khatib, MD, MHS
San Diego, California

May 5-8, 2002
North American Society of Pacing and Electrophysiology (NASPE) Annual Meeting
Causes of the Acquired Long QT Syndrome
Raymond L. Woosley, MD, PhD
San Diego, California

May 5-8, 2002
3rd International Symposium on Pneumococci and Pneumococcal Disease
Do Hospital Microbiology Laboratories Provide Reliable Estimates of Local Rates of Pneumococcal Drug Resistance
Joshua P. Metlay, MD, PhD
Anchorage, Alaska

May 3, 2002
Association of Pediatric Program Directors' Annual Spring Meeting
Integrating New QI Competencies into the Continuity Clinic Experience
Eva Schaff, MD, Greg Randolph, MD, MPH, and Julie J. Mohr, MSPH, PhD
Baltimore, Maryland

To Top

April 25, 2002
4th Annenberg Conference
Accountability in Clinical Research: Balancing Risk & Benefit
Robert M. Califf, MD
Indianapolis, Indiana

April 24-26, 2002
Accountability in Clinical Research
The Centers for Education & Research on Therapeutics: A National Initiative for Public/Private Partnership
Robert M. Califf, MD
Indianapolis, Indiana

April 15-19, 2002
John Sampson Lectureship -University of California, San Francisco
Developments on the Treatment of ST Elevation MI
Development in the Treatment of Heart Failure
Developments in the Treatment of Non-ST Elevation MI
Can Academic Centers Lead the Effort to Create a Cycle of Quality in Health Care?
Robert M. Califf, MD
San Francisco, California

April 6-9, 2002
Society for Healthcare Epidemiology of America 12th Annual Meeting
Fluoroquinolone (FQ) Resistance is Independently Associated with Increased Mortality in Nosocomial Escherichia coli (EC) and Klebsiella pneumoniae (KP) Infections
Ebbing Lautenbach, MD, MPH, MSCE
Salt Lake City, Utah

April 6-9, 2002
Society for Healthcare Epidemiology of America 12th Annual Meeting
Medication Errors in Fluoroquinolone Administration
Todd Barton, MD, Neil Fishman, MD, Ebbing Lautenbach, MD, MPH, MSCE
Salt Lake City, Utah

April 6-7, 2002
Annual Cardiovascular Update
The Cycle of Quality in the Treatment of ACS
Robert M. Califf, MD
Austin, Texas

April 4-5, 2002
Antimicrobial Strategies and Cardiothoracic Surgery Working Group
Robert M. Califf, MD
Bethesda, Maryland

To Top

March 24-27, 2002
American Society for Clinical Pharmacology and Therapeutics Annual Meeting
Metoclopramide and Tardive Dyskinesia: A Review of the FDA Adverse Event Reporting System
Douglas N. Shaffer, MD, MHS, and Marian I. Butterfield, MD, MPH
Atlanta, Georgia

March 23, 2002
7th Annual European Forum on Quality Improvement in Health Care
Microsystem Simulation - A Patient Safety Challenge
Julie J. Mohr, MSPH, PhD, and Paul Barach, MD, MPH
Edinburgh, Scotland

March 20, 2002
27th Annual Primary Care Update
Adverse Drug Reactions: A Focus on Drug Interactions
Raymond L. Woosley, MD, PhD
Tucson, Arizona

March 16-20, 2002
American College of Cardiology
Deficits in Knowledge Related to the QT Interval that Could Impact Patient Safety
Nancy M. Allen LaPointe, PharmD
Atlanta, Georgia

March 12, 2002
National Initiative for Children's Healthcare Quality's 1st Annual Forum for Improving Children's Health Care
Quality Improvement and Systems Thinking in Education
Paul Miles, MD, and Julie J. Mohr, MSPH, PhD
Tempe, Arizona

March 12, 2002
National Initiative for Children's Healthcare Quality's 1st Annual Forum for Improving Children's Health Care
Patient Safety Simulation
Julie J. Mohr, MSPH, PhD, and Paul Barach, MD, MPH
Tempe, Arizona

March 11, 2002
AHRQ's CERTs Program: An Opportunity to Maximize Interagency Collaboration
Center Overviews and Highlighted Projects
Lynn A. Bosco, MD, MPH, Robert M. Califf, MD, William H. Campbell, PhD, Marie R. Griffin, MD, Judith M. Kramer, MD, MS, Richard Platt, MD, MSc, Kenneth G. Saag, MD, MSc, Brian L. Strom, MD, Hugh H. Tilson, MD, DrPH, Phillip Walson, MD, Raymond L. Woosley, MD, PhD
Rockville, Maryland

To Top

February 23, 2002
The American College of Preventive Medicine, Preventive Medicine 2002
Preventing Adverse Effects of Pharmacotherapy
Brian L. Strom, MD, MPH
San Antonio, Texas

February 20-21, 2002
Visiting Professor – Midwest Heart Institute
Acute Coronary Syndrome in the 21st Century
Ischemic Cardiomyopathy in the 21st Century
Robert M. Califf, MD
Peoria, Illinois

February 12, 2002
CAQH Cardiac Initiative
Evaluation and Improving the Use of Life-Saving Medications in CAD and HF
Judith M. Kramer, MD, MS and Nancy Allen LaPointe, PharmD
Washington, DC

To Top

January 15, 2002
The University of North Carolina Pharmacoepidemiology Seminar
Applications of Pharmacoepidemiology Methods
Sean Hennessy, PharmD, PhD
Chapel Hill, North Carolina

January 15, 2002
The University of North Carolina Pharmacoepidemiology Seminar
Overview of Pharmacoepidemiology
Brian L. Strom, MD, MPH
Chapel Hill, North Carolina

January 11, 2002
Visiting Professor - The Cleveland Clinic Foundation
The Cycle of Quality in CV Disease
Robert M. Califf, MD
Cleveland, Ohio

January 4-5, 2002
ACC Task Force and Work Group Strategy Meeting
Robert M. Califf, MD
Atlanta, Georgia

To Top